Resource Library
Accelerating biopharmaceutical tech transfer to address unmet medical needs
Accelerated tech transfer timelines are becoming increasingly desirable to support the development and manufacture of biologics that have the potential to address significant unmet medical needs, such as COVID-19 therapies.
Timelines for a successful tech transfer are often determined by a variety of factors, including requirements and timelines for analytical development, equipment availability and raw materials.
This technical note describes how Samsung Biologics have successfully developed a number of innovative strategies as part of a tech transfer plan to support faster biologics development and manufacturing programs.
Accelerated tech transfer timelines are becoming increasingly desirable to support the development and manufacture of biologics that have the potential to address significant unmet medical needs, such as COVID-19 therapies.
Timelines for a successful tech transfer are often determined by a variety of factors, including requirements and timelines for analytical development, equipment availability and raw materials.
This technical note describes how Samsung Biologics have successfully developed a number of innovative strategies as part of a tech transfer plan to support faster biologics development and manufacturing programs.